Medicines Evaluation Unit

Medicines Evaluation Unit

Open Access statistics for Medicines Evaluation Unit, United Kingdom, covering academic research published from 2000 to 2024.

Open Access statistics for Medicines Evaluation Unit, United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

718


Total Open
Publications

462


Total
Citations

21K


Open Access
Percentage

64%


Total
Publications

718


Total Open
Publications

462


Total
Citations

21K

Website

download

Breakdown

18% 35% 11% 36%

Publisher Open

18%

Both

35%

Other Platform Open

11%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

149

Hybrid 31%

118

No Guarantees 30%

116

Other Platform Open

Domain 69%

230

Institution 46%

152

Other Internet 15%

50

Public 9%

29

Preprint 2%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
225
Europe PMC
Domain
126
The University of Manchester - Research Explorer
Institution
60
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
48
University of Ferrara - Institutional Research Information System University of Ferrara
Institution
29
Semantic Scholar
Public
25
Taylor and Francis Group - Dove Medical Press
Other Internet
23
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
21
University of Edinburgh - Edinburgh Research Explorer
Institution
17
University College London - UCL Discovery
Institution
13
1 / 9

Data updated 7 April 2025

Share

Share

Share